Medicare Enrolled

Dr. Souad Enakuaa, MD

Endocrinology · Webster, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
600 N KOBAYASHI STE 312, Webster, TX 77598
2817248333
In practice since 2015 (10 years)
NPI: 1043606619 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Enakuaa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Enakuaa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Enakuaa

Dr. Souad Enakuaa is an endocrinology in Webster, TX, with 10 years in practice. Based on federal Medicare data, Dr. Enakuaa performed 2,019 Medicare services across 534 unique beneficiaries.

Between the years covered by Open Payments, Dr. Enakuaa received a total of $10,005 from 55 pharmaceutical and/or device companies across 600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Enakuaa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ Top 21% volume in TX$ $10,005 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,019
Medicare services
Top 21% in TX for endocrinology
534
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~202 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)1,140$19$69
Office visit, established patient (30-39 min)384$87$385
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report149$26$104
Office visit, established patient, complex (40-54 min)149$136$540
New patient office visit (45-59 min)59$121$503
New patient office visit, complex (60-74 min)57$154$664
Ultrasound scan of head and neck soft tissue26$79$339
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin21$47$184
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle19$56$219
Office visit, established patient (20-29 min)15$54$272
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,005
Total received (2019-2024)
Avg $1,668/year across 6 years
Top 32% in TX for endocrinology
55
Companies
600
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,005 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,168
2023
$2,739
2022
$2,481
2021
$1,331
2020
$125
2019
$161

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$1,526
Novo Nordisk Inc
$1,017
Corcept Therapeutics
$724
Lilly USA, LLC
$707
AstraZeneca Pharmaceuticals LP
$522
ABBVIE INC.
$426
Amgen Inc.
$347
Radius Health, Inc.
$298
Boehringer Ingelheim Pharmaceuticals, Inc.
$297
Ascensia Diabetes Care Us Inc.
$273
Xeris Pharmaceuticals, Inc.
$235
Mannkind Corporation
$217
OPKO Pharmaceuticals, LLC
$197
IBSA Pharma Inc.
$182
Amarin Pharma Inc.
$168
CeQur Corporation
$167
SANOFI-AVENTIS U.S. LLC
$161
Mallinckrodt Hospital Products Inc.
$161
Embecta Corp.
$146
Esperion Therapeutics, Inc.
$139
Bayer HealthCare Pharmaceuticals Inc.
$134
Insulet Corporation
$133
Vifor Pharma, Inc.
$124
Zealand Pharma US, Inc.
$124
RECORDATI_RARE_DISEASES_INC.
$123
Alexion Pharmaceuticals, Inc.
$116
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$99
BETA BIONICS, INC.
$93
DEXCOM, INC.
$92
MannKind Corporation
$87
Astellas Pharma US Inc
$81
Bayer Healthcare Pharmaceuticals Inc.
$78
Travere Therapeutics, Inc.
$73
Ultragenyx Pharmaceutical Inc.
$71
Amneal Pharmaceuticals LLC
$64
Intuity Medical Inc
$62
AbbVie Inc.
$61
Merck Sharp & Dohme LLC
$50
Alvogen Inc
$46
Medtronic, Inc.
$38
Amryt Pharma Holdings Ltd
$37
Ipsen Biopharmaceuticals, Inc
$36
Phathom Pharmaceuticals, Inc.
$32
Verity Pharmaceuticals Inc.
$27
Horizon Therapeutics plc
$25
Becton, Dickinson and Company
$24
CorMedix Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$22
Azurity Pharmaceuticals, Inc.
$20
Antares Pharma, Inc.
$19
Acella Pharmaceuticals, LLC
$18
Novartis Pharmaceuticals Corporation
$18
Abbott Laboratories
$16
Ascendis Pharma Inc
$16
Averitas Pharma Inc.
$14
Top 3 companies account for 32.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AFREZZA · AVYCAZ · BAQSIMI · BD Nano 2nd Gen Pen Needle · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · DefenCath · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · EVERSENSE E3 SMART TRANSMITTER KIT · Edarbyclor · FARXIGA · FREESTYLE LIBRE 3 · GATTEX · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · MOUNJARO · MYCAPSSA · NEXLETOL · NOCDURNA · NP Thyroid 60 · Omnipod · Ozempic · PREVYMIS · Pogo Automatic Blood Glucose Monitoring System · QUTENZA · RAYALDEE · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · STRENSIQ · SYNJARDY · SYNTHROID · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tymlos · ULTOMIRIS · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · VOQUEZNA · Vascepa · Veltassa · Veozah · Wegovy · XIFAXAN · ZEGALOGUE · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $496 per 100 Medicare services performed
Looking for a endocrinology in Webster?
Compare endocrinologys in the Webster area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
97
Per 100K population
2.0
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Enakuaa is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Enakuaa experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Enakuaa performed 1,140 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Enakuaa receive payments from pharmaceutical companies?
Yes. Dr. Enakuaa received a total of $10,005 from 55 companies across 600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Enakuaa's costs compare to other endocrinologys in Webster?
Dr. Enakuaa's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Enakuaa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →